Author Strauss, Arne

• 2023 | Journal Article | 
  ​ ​Optimizing the structure of interdisciplinary tumor boards for effective cancer care​
  Braulke, F.; Kober, K.; Arndt, A.; Papendick, M.; Strauss, A.; Kramm, C. M. & Thoms, K.-M. et al.​ (2023) 
  Frontiers in Oncology, 13.​ DOI: https://doi.org/10.3389/fonc.2023.1072652 
  ​Details  DOI 

• 2022 | Journal Article | 
  ​ ​Understanding long-term continence rates after robot-assisted laparoscopic prostatectomy – one-year follow-up on “Cognitive ability as a non-modifiable risk factor for post-prostatectomy urinary incontinence”​
  Reichert, M.; Ploeger, H. M.; Uhlig, A.; Strauss, A.; Henniges, P.; Trojan, L. & Mohr, M.​ (2022) 
  Frontiers in Surgery, 9.​ DOI: https://doi.org/10.3389/fsurg.2022.1055880 
  ​Details  DOI 

• 2022 | Journal Article
  ​ ​Ein bemerkenswerter Fall: Eine atypisch gelegene Urachuszyste nach kontinenter Harnableitung mittels MAINZ-Pouch mit Appendixstoma.​
  Reichert, M.; Strauss, A.; Mohr, M. N.; Schneider, T. R.; Trojan, L. & Hahn, O.​ (2022) 
  Aktuelle Urologie,.​ DOI: https://doi.org/10.1055/a-1909-5871 
  ​Details  DOI 

• 2021 | Journal Article
  ​ ​Liver enzyme elevation after 177 Lu-PSMA radioligand therapy for metastasized castration-resistant prostate cancer​
  Treiber, H.; Koenig, A.; Neesse, A.; Richter, A.; Sahlmann, C. O. & Strauss, A.​ (2021) 
  Journal of Nuclear Medicine, pp. jnumed.120.258533​.​ DOI: https://doi.org/10.2967/jnumed.120.258533 
  ​Details  DOI 

• 2019 | Journal Article | 
  ​ ​Enhancing PSMA-uptake with androgen deprivation therapy – a new way to detect prostate cancer metastases?​
  Leitsmann, C.; Thelen, P.; Schmid, M.; Meller, J.; Sahlmann, C.-O.; Meller, B. & Trojan, L. et al.​ (2019) 
  International Braz J Urol, 45(3) pp. 459​-467​.​ DOI: https://doi.org/10.1590/s1677-5538.ibju.2018.0305 
  ​Details  DOI 

• 2019 | Journal Article
  ​ ​Tumor laterality in renal cancer as a predictor of survival in large patient cohorts: A STROBE compliant study: Erratum​
  Strauss, A.; Uhlig, J.; Lotz, J.; Trojan, L. & Uhlig, A.​ (2019) 
  Medicine, 98(20) pp. e15790​.​ DOI: https://doi.org/10.1097/MD.0000000000015790 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​Preventive Services Utilization Among Cancer Survivors Compared to Cancer-free Controls​
  Uhlig, A.; Uhlig, J.; Strauss, A.; Trojan, L.; Lotz, J.   & Hosseini, A. S. A.​ (2018) 
  The Open Public Health Journal, 11(1) pp. 122​-133​.​ DOI: https://doi.org/10.2174/1874944501811010122 
  ​Details  DOI 

• 2018 | Journal Article | 
  ​ ​Primary bladder adenocarcinoma: Case report with long-term follow-up​
  Uhlig, A.; Behnes, C. L.; Strauss, A.; Trojan, L.; Uhlig, J. & Leitsmann, C.​ (2018) 
  Urology Case Reports, 18 pp. 64​-66​.​ DOI: https://doi.org/10.1016/j.eucr.2018.02.006 
  ​Details  DOI 

• 2016 | Journal Article
  ​ ​See the unseen: Mesorectal lymph node metastases in prostate cancer​
  Hijazi, S.; Meller, B.; Leitsmann, C.; Strauss, A.; Ritter, C.; Lotz, J.   & Meller, J. et al.​ (2016) 
  The Prostate, 76(8) pp. 776​-780​.​ DOI: https://doi.org/10.1002/pros.23168 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article | 
  ​ ​Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours​
  Bremmer, F.; Schallenberg, S.; Jarry, H.; Kueffer, S.; Kaulfuss, S.; Burfeind, P. & Strauss, A. et al.​ (2015) 
  Oncotarget, 6(32) pp. 33426​-33437​.​ DOI: https://doi.org/10.18632/oncotarget.5288 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article | 
  ​ ​Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors​
  Kluemper, N.; Syring, I.; Offermann, A.; Shaikhibrahim, Z.; Vogel, W.; Mueller, S. C. & Ellinger, J. et al.​ (2015) 
  Diagnostic Pathology, 10 art. 165​.​ DOI: https://doi.org/10.1186/s13000-015-0398-6 
  ​Details  DOI  PMID  PMC  WoS 

• 2015 | Journal Article | 
  ​ ​CK19 is a sensitive marker for yolk sac tumours of the testis​
  Bremmer, F.; Stroebel, P.; Jarry, H.; Strecker, J.; Gaisa, N.; Strauss, A. & Schweyer, S. et al.​ (2015) 
  Diagnostic Pathology, 10 art. UNSP 7​.​ DOI: https://doi.org/10.1186/s13000-015-0243-y 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Journal Article | 
  ​ ​Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC)​
  Bremmer, F.; Jarry, H.; Strauss, A.; Behnes, C. L.; Trojan, L. & Thelen, P.​ (2014) 
  SpringerPlus, 3 art. 574​.​ DOI: https://doi.org/10.1186/2193-1801-3-574 
  ​Details  DOI  PMID  PMC  WoS 

• 2014 | Journal Article
  ​ ​Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma​
  Behnes, C. L.; Bremmer, F.; Hemmerlein, B.; Strauss, A.; Stroebel, P. & Radzun, H.-J.​ (2014) 
  Virchows Archiv, 464(2) pp. 191​-196​.​ DOI: https://doi.org/10.1007/s00428-013-1523-0 
  ​Details  DOI  PMID  PMC  WoS 

• 2013 | Conference Abstract
  ​ ​Analysis of putative resistance mechanisms in recent treatments targeting the androgen receptor in castration-resistant prostate cancer (CRPC)​
  Thelen, P.; Walleck, E.; Bremmer, F.; Trojan, L. & Strauss, A.​ (2013)
  Journal of Clinical Oncology, 31(6) ​Genitourinary Cancers Symposium of the Conquer-Cancer-Foundation of American-Society-of-Clinical-Oncology (ASCO)​, Orlando, FL.
  Alexandria​: Amer Soc Clinical Oncology.
  ​Details  WoS 

• 2013 | Journal Article | 
  ​ ​Collecting Duct Carcinomas Represent a Unique Tumor Entity Based on Genetic Alterations​
  Becker, F.; Junker, K.; Parr, M.; Hartmann, A.; Fuessel, S.; Toma, M. & Grobholz, R. et al.​ (2013) 
  PLoS ONE, 8(10) art. e78137​.​ DOI: https://doi.org/10.1371/journal.pone.0078137 
  ​Details  DOI  PMID  PMC  WoS 

• 2013 | Journal Article
  ​ ​Testosterone Boosts for Treatment of Castration Resistant Prostate Cancer: An Experimental Implementation of Intermittent Androgen Deprivation​
  Thelen, P.; Heinrich, E.; Bremmer, F.; Trojan, L. & Strauss, A.​ (2013) 
  The Prostate, 73(15) pp. 1699​-1709​.​ DOI: https://doi.org/10.1002/pros.22711 
  ​Details  DOI  PMID  PMC  WoS 

• 2013 | Journal Article
  ​ ​Synergistic effects of histone deacetylase inhibitor in combination with mTOR inhibitor in the treatment of prostate carcinoma​
  Thelen, P.; Krahn, L.; Bremmer, F.; Strauss, A.; Brehm, R. & Loertzer, H.​ (2013) 
  International Journal of Molecular Medicine, 31(2) pp. 339​-346​.​ DOI: https://doi.org/10.3892/ijmm.2012.1221 
  ​Details  DOI  PMID  PMC  WoS 

• 2013 | Journal Article | 
  ​ ​Laser-supported partial laparoscopic nephrectomy for renal cell carcinoma without ischaemia time​
  Loertzer, H.; Strauss, A.; Ringert, R. H. & Schneider, P.​ (2013) 
  BMC Urology, 13 art. 31​.​ DOI: https://doi.org/10.1186/1471-2490-13-31 
  ​Details  DOI  PMID  PMC  WoS 

• 2012 | Conference Abstract
  ​ ​Histone deacetylase inhibitor (HDACi) LBH589 interference with androgen receptor expression transcriptional activity in prostate cancer cells.​
  Thelen, P.; Ringert, R.-H. & Strauss, A.​ (2012)
  Journal of Clinical Oncology, 30(15) ​48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)​, Chicago, IL.
  Alexandria​: Amer Soc Clinical Oncology.
  ​Details  WoS 

Researcher

Sort

Items per Page